Ning Li Udayan Guha Chul Kim Leah Ye Jordan Cheng Feng Li David Chia Fang Wei David T W Wong
10.3389/fonc.2020.01240
Front Oncol
2020 Jul 24;10:1240.
acquired resistance gene mutation liquid biopsy local ablative therapy non-small cell lung cancer osimertinib
CC BY
https://pubmed.ncbi.nlm.nih.gov/32793495/
Case Reports
PMC7393232
32793495
Longitudinal Monitoring of EGFR and PIK3CA Mutations by Saliva-Based EFIRM in Advanced NSCLC Patients With Local Ablative Therapy and Osimertinib Treatment: Two Case Reports
2020